Symbiox Investment & Trading Co quarterly results and financials

Symbiox Investment & Trading Co (BSE 539278)₹1.58+5.33%(9 Nov 2026 close)Other Financial Services

Key facts

In the Mar 2026 quarter (standalone), Symbiox Investment & Trading Co reported sales of ₹0.84 Cr, down 33.3% from Mar 2025, and net profit of ₹0.02 Cr. For the year to Mar 2026, sales were ₹1.61 Cr and net profit ₹0.16 Cr.

Sales (Mar 2026): ₹0.84 Cr
Net profit (Mar 2026): ₹0.02 Cr
Sales (FY Mar 2026): ₹1.61 Cr
Net profit (FY Mar 2026): ₹0.16 Cr
EPS (Mar 2026): ₹0.00
Borrowings (Mar 2026): ₹0 Cr

Company filings, standalone accounts; latest reported quarter Mar 2026

Symbiox Investment & Trading Co quarterly results

₹ crore unless stated; each column is a quarter.

Symbiox Investment & Trading Co Quarterly results
	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	1.37	1.24	0.19	1.13	0.32	0.76	0.46	1.26	0.47	0.24	0.10	0.84
Expenses	1.34	1.09	0.26	1.23	0.31	0.32	0.24	1.66	0.38	0.16	0.08	0.82
Operating Profit	0.02	0.14	−0.06	−0.09	0.00	0.43	0.21	−0.39	0.08	0.07	0.01	0.01
OPM %	2.2%	12.2%	−38.9%	−8.9%	3.2%	58.7%	49.0%	−32.0%	19.6%	34.8%	22.3%	2.4%
Other Income	0.11	0.02	0.05	0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	0.16	0.19	−0.02	−0.08	0.02	0.45	0.23	−0.41	0.10	0.09	0.03	0.03
Tax %	26.6%	27.7%	0.0%	−57.2%	0.0%	27.2%	27.2%	−27.6%	22.2%	24.9%	0.0%	0.0%
Net Profit	0.12	0.14	−0.02	−0.04	0.02	0.34	0.17	−0.31	0.08	0.07	0.02	0.02
EPS (Rs)	0.03	0.03	0.00	0.00	0.00	0.10	0.04	−0.09	0.01	0.01	0.00	0.00

Symbiox Investment & Trading Co profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Symbiox Investment & Trading Co Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	2.08	2.03	1.87	0.91	1.05	2.09	1.84	4.01	4.14	2.78	1.61	1.65
Expenses	2.02	3.31	2.73	1.72	1.98	3.01	1.66	3.79	3.89	2.52	1.40	1.44
Operating Profit	0.05	−1.27	−0.85	−0.80	−0.92	−0.91	0.17	0.21	0.24	0.25	0.20	0.17
OPM %	2.9%	−63.3%	−46.2%	−90.0%	−89.4%	−44.2%	9.9%	5.5%	6.1%	9.4%	13.2%	10.3%
Other Income	0.00	1.44	1.03	0.84	0.95	1.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	0.07	0.18	0.19	0.05	0.04	0.10	0.20	0.23	0.26	0.27	0.22	0.25
Tax %	33.3%	29.4%	27.8%	124.9%	33.3%	22.2%	26.3%	27.2%	15.9%	26.8%	23.8%	—
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.00	0.00	0.00	0.00	—
Net Profit	0.05	0.12	0.14	−0.02	0.03	0.08	0.15	0.17	0.22	0.20	0.16	0.19
EPS (Rs)	0.00	0.03	0.03	0.00	0.00	0.01	0.03	0.04	0.06	0.05	0.04	0.02
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Symbiox Investment & Trading Co balance sheet

₹ crore, at each year end.

Symbiox Investment & Trading Co Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	31.37	31.28	31.27	31.28	31.30	31.30	31.29	31.30	31.28	31.29	31.31	31.32
Reserves	−0.72	−0.68	−0.57	−0.44	−0.41	−0.38	−0.32	−0.11	0.03	0.23	0.43	0.59
Borrowings	0.00	0.27	0.27	0.27	0.27	0.25	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	0.43	0.19	0.94	1.36	2.68	0.84	2.30	0.65	1.44	0.30	0.23	0.10
Total Liabilities	31.08	31.06	31.91	32.47	33.84	32.01	33.27	31.84	32.75	31.82	31.97	32.01
Fixed Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.00
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	30.16	13.25	14.63	15.05	16.61	16.99	17.98	17.59	12.75	9.92	12.75	15.39
Other Assets	0.92	17.81	17.28	17.42	17.23	15.02	15.29	14.25	20.00	21.89	19.21	16.62
Inventories	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.20	0.08	1.29	0.62
Trade receivables	0.00	0.00	0.34	1.61	1.27	0.00	0.00	0.88	0.81	0.03	0.17	0.30
Cash & equivalents	0.44	0.07	0.17	0.24	0.11	0.00	0.14	0.18	0.53	0.30	1.05	1.16
Total Assets	31.08	31.06	31.91	32.47	33.84	32.01	33.27	31.84	32.75	31.82	31.97	32.01

Symbiox Investment & Trading Co cash flow

₹ crore, for each year.

Symbiox Investment & Trading Co Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	−0.61	−17.18	1.48	0.47	1.42	0.26	1.13	−0.34	−4.46	−3.05	3.57	2.72
Cash from investing activity	0.91	16.89	−1.40	−0.42	−1.56	−0.39	−1.01	0.41	4.84	2.84	−2.85	−2.62
Cash from financing activity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net cash flow	0.27	−0.36	0.09	0.05	−0.11	−0.10	0.13	0.03	0.34	−0.22	0.74	0.10
Capex	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.00	0.00
Free cash flow	−0.63	−17.21	1.49	0.49	1.42	0.26	1.15	−0.36	−4.48	−3.06	3.57	2.74
CFO / OP %	−3,100.0%	−28,583.0%	−116.0%	−56.0%	−189.1%	−31.0%	−127.0%	−183.0%	−2,009.0%	−1,200.0%	1,392.0%	1,333.0%

Symbiox Investment & Trading Co ratios

Working-capital days and returns, by year.

Symbiox Investment & Trading Co Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	0	0	60	314	511	0	0	174	73	2	21	66
Inventory days	4	2	1	2	0	0	0	0	24	9	225	230
Days payable	0	0	87	174	—	—	—	—	150	21	26	0
Cash conversion cycle	4	2	−26	142	511	0	0	174	−54	−10	220	296
Working capital days	12	3,096	2,925	3,108	5,860	4,984	2,258	2,679	1,648	1,885	2,364	7,001
ROCE %	0.1%	0.2%	0.6%	0.6%	0.1%	0.1%	0.3%	0.6%	0.7%	0.8%	0.8%	0.7%

Symbiox Investment & Trading Co: frequently asked questions

What are the latest quarterly results of Symbiox Investment & Trading Co?

For the Mar 2026 quarter, Symbiox Investment & Trading Co reported sales of ₹0.84 Cr, down 33.3% year on year and net profit of ₹0.02 Cr. The operating margin was 2.4%.

What is the annual revenue of Symbiox Investment & Trading Co?

Symbiox Investment & Trading Co's sales for the year to Mar 2026 were ₹1.61 Cr; over the last twelve months they were ₹1.65 Cr.

What is the net profit of Symbiox Investment & Trading Co?

Net profit for the year to Mar 2026 was ₹0.16 Cr, and ₹0.19 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.02.

How much debt does Symbiox Investment & Trading Co have?

Symbiox Investment & Trading Co reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹1.16 Cr.

What is the free cash flow of Symbiox Investment & Trading Co?

Cash from operations was ₹2.72 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹2.74 Cr.

Loading…